CoChat

Organic small-molecule NIR-II fluorophores for tumor phototheranostics

Open access
Xiang, Dan, Wang, Zhichao, Zheng, Hongwei, Tang, Yuqi, Li, Quan · 2026 · Light: Science & Applications

The DOI matches its Crossref record; 244 of the 245 references it cites were found in a registry or an index; 80 of the 367 sources its claims cite were checked for support.

Abstract

Near-infrared II (NIR-II) fluorophores possess transformative potential for biomedical applications, owing to their deep-tissue penetration, reduced tissue autofluorescence, and low phototoxicity. Recent breakthroughs in molecular engineering have accelerated the development of NIR-II organic small-molecule fluorophores based on versatile scaffolds, including cyanine, boron dipyrromethene, benzobisthiadiazole, xanthene, cyano-based derivatives, and small-molecule metal complexes. This review systematically summarizes the molecular engineering strategies, photophysical properties, and structure-function relationships of NIR-II fluorophores in the last five years. We highlight recent breakthroughs in their theranostic applications, including high-resolution deep-tissue imaging and efficient phototherapeutic modalities such as photodynamic and photothermal therapy. Finally, we present forward-looking perspectives on current challenges and emerging opportunities, aiming to provide insights for promoting continued innovation and clinical translation in this rapidly advancing field.

Overview

CoChat Summary

TL;DR

This review surveys organic small-molecule NIR-II fluorophores built on cyanine, BODIPY, BBTD, xanthene, cyano-based, and small-molecule metal-complex scaffolds, covering molecular design strategies, photophysical properties, and structure–function relationships over the last five years. It then catalogs their use in deep-tissue fluorescence/photoacoustic imaging, image-guided surgery, and photodynamic/photothermal tumor therapy, and closes with translational challenges.

Key findings

  • Emission red-shifting is achieved mainly by polymethine-chain elongation, donor/acceptor engineering, π-conjugation extension, and heteroatom substitution; each added methylene unit typically gives ~100 nm red-shift but plateaus as chains become conformationally flexible and prone to non-radiative decay.
  • Reported performance highlights include: CTB1125 with λem 1125 nm and 10.2% quantum yield in hexane (4.84% in water), described as surpassing all previously reported fluorophores emitting beyond 1100 nm; FE-IDMN NPs with PCE 82.6%; BETT-2 NPs with PCE 56.6%; DPTPzIr NPs with PCE 60.5%; and mCy890 NPs with PCE 51%.
  • Imaging benchmarks cited include SJ-1271-Micelles NIR-IIb vascular SNRs of 6.79 (hindlimb), 3.39 (abdomen), 5.87 (brain) and tumor TNR/SNR peaking at 3.0/4.76; NIR-AC4 Bio NPs reaching TNR 15 and AaNPs SBR 14.32; FBP 912 with t1/2 ≈ 6.1 h, SNR 8.2, and 65% renal clearance at 12 h; and 5SGNPs with pulmonary SNR of 124.
  • Activatable and targeted designs (pH/viscosity, GSH, H2S, NO, ATP, ROS, APN, CA, GLUT1, mitochondria) are presented as the main route to overcome the "always-on" background and hepatic accumulation of conventional cyanines.

Methods

  • Narrative review, not primary research: the authors systematically summarize molecular engineering strategies, photophysical properties, and structure–function relationships of NIR-II organic small-molecule fluorophores published in the last five years.
  • Evidence base is the published literature, organized by scaffold class (cyanine, BBTD, BODIPY, xanthene, cyano-based, small-molecule metal complexes) with six accompanying tables of λabs, λem, quantum yield, and molar extinction coefficient values and their original references.
  • Applications are grouped into bioimaging (fluorescence and photoacoustic) and phototherapy (PDT, PTT, gas therapy, synergistic combinations), with representative in vivo mouse models (4T1, H22, MCF-7, CT26, GL261, Pan02, A549, HCT-116, HepG2) described qualitatively.

Limitations

  • Stated by the authors: insufficient fluorescence intensity (low quantum yields, worsened by water-induced non-radiative relaxation); poor water solubility and biocompatibility, with PEGylation/nanoparticle assembly often causing rapid hepatic uptake and an unresolved trade-off between extended conjugation and hydrophilicity; inadequate targeting ability and specificity, with many systems lacking quantitative comparisons of targeting efficiency; and limited blood-brain barrier penetration, where systematic evaluation of penetration efficiency, long-term biosafety, and clinical relevance is scarce.
  • Evident from the text: as a review, it reports no new experimental data, and the performance figures cited are drawn from heterogeneous primary studies using differing solvents, reference standards for quantum yield (IR-26, ICG, IR-1061, ECXb, FT-BBT, single-walled carbon nanotubes), and measurement conditions, so cross-study comparisons are not normalized.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41377-026-02212-w

Cites

244 of 245 references verified0 citation errors · 1 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Overview of organic small-molecule NIR-II fluorophores for tumor phototheranostics
Fig. 1 Overview of organic small-molecule NIR-II fluorophores for tumor phototheranosticsCC BY · PubMed Central
Fig. 2 Chemical structures of organic small-molecule NIR-II cyanine-based structures
Fig. 2 Chemical structures of organic small-molecule NIR-II cyanine-based structuresCC BY · PubMed Central
Fig. 3 Design strategies for NIR-II cyanine-based fluorophores. a i) Synthetic route to cyazulenes (CA965, CA985, and CA1025). ii) Adjustment of cycloalkenes in NIR-II cyazulene fluorophores. iii) Normalization of absorption and emission spectra of CA965, CA985, and CA1025 in CHCl3. Reproduced with permission100. Copyright 2025, Wiley-VCH GmbH. b i) Structure of indocyanine polymethine fluorophores with indocyanine terminal groups. ii) Structures and emission wavelength of reported indocyanine polymethines and Cy15s reported here. The blue balls indicate indocyanine terminal groups, and the green numbers represent the number of carbon atoms in the conjugation chain. iii) Normalized absorption spectra of representative Cy15s (5 × 10−6 mol/L) in DCM. iv) Normalized emission spectra of representative Cy15s (5 × 10−6 mol/L) in deuterated DCM under 980 nm laser excitation. Reproduced with permission101. Copyright 2025, Elsevier Ltd
Fig. 3 Design strategies for NIR-II cyanine-based fluorophores. a i) Synthetic route to cyazulenes (CA965, CA985, and CA1025). ii) Adjustment of cycloalkenes in NIR-II cyazulene fluorophores. iii) Normalization of absorption and emission spectra of CA965, CA985, and CA1025 in CHCl3. Reproduced with permission100. Copyright 2025, Wiley-VCH GmbH. b i) Structure of indocyanine polymethine fluorophores with indocyanine terminal groups. ii) Structures and emission wavelength of reported indocyanine polymethines and Cy15s reported here. The blue balls indicate indocyanine terminal groups, and the green numbers represent the number of carbon atoms in the conjugation chain. iii) Normalized absorption spectra of representative Cy15s (5 × 10−6 mol/L) in DCM. iv) Normalized emission spectra of representative Cy15s (5 × 10−6 mol/L) in deuterated DCM under 980 nm laser excitation. Reproduced with permission101. Copyright 2025, Elsevier LtdCC BY · PubMed Central
Fig. 4 Design strategies for targeted cyanine-based fluorophores. a i) Schematic illustration of design strategy and response mechanism of NIR-II NSCyanine dyes to pH and viscosity in diseases. ii) NSCy-1015 in pH 7.4 and pH 2.2 CPBS buffer solutions (containing 50% CH3CN for dispersed solution). iii) NSCy-1015 in different pH buffer solutions (containing 50% CH3CN), λex = 808 nm. Insert: NIR-II fluorescence images of fluorophores in pH 7.4 and pH 2.2 buffer solutions (808 nm laser, 50 mW cm−2, 50 ms). Reproduced with permission88. Copyright 2023, Wiley-VCH GmbH. b i) The molecular design strategy of dimeric HCy photothermal transducers and molecular structures of dimeric HCy, dimeric mBHCy, and dimeric oBHCy. ii) Absorption spectra and iii) fluorescence emission spectra of dimeric HCy, dimeric mBHCy, and dimeric oBHCy all in DMSO (excited at 735 nm for NIR-I spectra and at 980 nm for NIR-II spectra). Reproduced with permission96. Copyright 2024, American Chemical Society
Fig. 4 Design strategies for targeted cyanine-based fluorophores. a i) Schematic illustration of design strategy and response mechanism of NIR-II NSCyanine dyes to pH and viscosity in diseases. ii) NSCy-1015 in pH 7.4 and pH 2.2 CPBS buffer solutions (containing 50% CH3CN for dispersed solution). iii) NSCy-1015 in different pH buffer solutions (containing 50% CH3CN), λex = 808 nm. Insert: NIR-II fluorescence images of fluorophores in pH 7.4 and pH 2.2 buffer solutions (808 nm laser, 50 mW cm−2, 50 ms). Reproduced with permission88. Copyright 2023, Wiley-VCH GmbH. b i) The molecular design strategy of dimeric HCy photothermal transducers and molecular structures of dimeric HCy, dimeric mBHCy, and dimeric oBHCy. ii) Absorption spectra and iii) fluorescence emission spectra of dimeric HCy, dimeric mBHCy, and dimeric oBHCy all in DMSO (excited at 735 nm for NIR-I spectra and at 980 nm for NIR-II spectra). Reproduced with permission96. Copyright 2024, American Chemical SocietyCC BY · PubMed Central
Fig. 5 Chemical structures of organic small-molecule NIR-II benzobisthiadiazole-based fluorophores
Fig. 5 Chemical structures of organic small-molecule NIR-II benzobisthiadiazole-based fluorophoresCC BY · PubMed Central
Fig. 6 Design strategy for NIR-II benzobisthiadiazole-based fluorophores. a i) Chemical structures, ii) optimized ground-state (S0) geometries, and iii) the HOMO and LUMO distributions of B1T, B2T, B3T, B2TA, and B3TA. Reproduced with permission129. Copyright 2023, Wiley-VCH GmbH. b i) HOMO-LUMO (highest occupied molecular orbitals-lowest unoccupied molecular orbitals) bandgaps of the fluorophores containing different thiadiazolo quinoxaline-based acceptors. ii) Normalized absorption spectra of the NPs in water. iii) Normalized emission spectra of the NPs in water. Reproduced with permission131. Copyright 2023, Wiley-VCH GmbH
Fig. 6 Design strategy for NIR-II benzobisthiadiazole-based fluorophores. a i) Chemical structures, ii) optimized ground-state (S0) geometries, and iii) the HOMO and LUMO distributions of B1T, B2T, B3T, B2TA, and B3TA. Reproduced with permission129. Copyright 2023, Wiley-VCH GmbH. b i) HOMO-LUMO (highest occupied molecular orbitals-lowest unoccupied molecular orbitals) bandgaps of the fluorophores containing different thiadiazolo quinoxaline-based acceptors. ii) Normalized absorption spectra of the NPs in water. iii) Normalized emission spectra of the NPs in water. Reproduced with permission131. Copyright 2023, Wiley-VCH GmbHCC BY · PubMed Central
Fig. 7 Chemical structures of organic small-molecule NIR-II BODIPY-based fluorophores
Fig. 7 Chemical structures of organic small-molecule NIR-II BODIPY-based fluorophoresCC BY · PubMed Central
Fig. 8 Design strategies for NIR-II BODIPY-based fluorophores. a i) Design strategy for BOIMPY acceptor. ii) The chemical structure of TPEB and TPAB. iii) The absorption spectra and iv) emission spectra in toluene of TPEB and TPAB (10 μM). Reproduced with permission166. Copyright 2025, Wiley-VCH GmbH. b i) Molecular engineering and photophysical properties of the BODIPY derivatives 1–5. ii) Normalized absorption spectra of compounds 1–5, 10 µM in dichloromethane. iii) Wavelength shifts of the BODIPY derivatives (1, 2, 4, 5) compared with compound 3 as a reference. iv) Normalized fluorescence spectra of compounds 1–5, 10 µM in dichloromethane, excited at 808 nm. v) Frontier molecular orbitals and relative energies of compounds 1–5. Reproduced with permission164. Copyright 2024, Wiley-VCH GmbH
Fig. 8 Design strategies for NIR-II BODIPY-based fluorophores. a i) Design strategy for BOIMPY acceptor. ii) The chemical structure of TPEB and TPAB. iii) The absorption spectra and iv) emission spectra in toluene of TPEB and TPAB (10 μM). Reproduced with permission166. Copyright 2025, Wiley-VCH GmbH. b i) Molecular engineering and photophysical properties of the BODIPY derivatives 1–5. ii) Normalized absorption spectra of compounds 1–5, 10 µM in dichloromethane. iii) Wavelength shifts of the BODIPY derivatives (1, 2, 4, 5) compared with compound 3 as a reference. iv) Normalized fluorescence spectra of compounds 1–5, 10 µM in dichloromethane, excited at 808 nm. v) Frontier molecular orbitals and relative energies of compounds 1–5. Reproduced with permission164. Copyright 2024, Wiley-VCH GmbHCC BY · PubMed Central
Fig. 9 Chemical structures of organic small-molecule NIR-II xanthene-based fluorophores
Fig. 9 Chemical structures of organic small-molecule NIR-II xanthene-based fluorophoresCC BY · PubMed Central
Fig. 10 Design strategies for activatable NIR-II xanthene-based fluorophores. a i) Structures of the newly designed rhodamine-based NIR-II PA dyes GX. ii) The theoretical calculations of HOMO-LUMO gaps for rhodamine B, CS, and GX-5. Reproduced with permission184. Copyright 2024, Wiley-VCH GmbH. b i) The reported activated probes platform. ii) Rational design of the novel activated probes platform NIRII-HD dyes. Reproduced with permission173. Copyright 2022, Wiley-VCH GmbH
Fig. 10 Design strategies for activatable NIR-II xanthene-based fluorophores. a i) Structures of the newly designed rhodamine-based NIR-II PA dyes GX. ii) The theoretical calculations of HOMO-LUMO gaps for rhodamine B, CS, and GX-5. Reproduced with permission184. Copyright 2024, Wiley-VCH GmbH. b i) The reported activated probes platform. ii) Rational design of the novel activated probes platform NIRII-HD dyes. Reproduced with permission173. Copyright 2022, Wiley-VCH GmbHCC BY · PubMed Central
Fig. 11 Chemical structures of organic small-molecule NIR-II cyano-based fluorophores
Fig. 11 Chemical structures of organic small-molecule NIR-II cyano-based fluorophoresCC BY · PubMed Central
Fig. 12 Design strategies for NIR-II cyano-based fluorophores. a i) Schematic diagram of side-chain phenyl isomerization-induced spatial conjugation and backbone interlocking for simultaneous enhancement of photothermal properties and NIR-II emission. ii) Ԑ and iii) photoluminescence (PL) spectra of six fluorophore NPs (Ex = 660 nm laser). Reproduced with permission189. Copyright 2025, Wiley-VCH GmbH. b i) the preparation and in situ self-assembly process of MSDP NPs. ii) The independent gradient model based on the Hirshfeld partition analysis of the dimer of M. Reproduced with permission191. Copyright 2025, Wiley-VCH GmbH
Fig. 12 Design strategies for NIR-II cyano-based fluorophores. a i) Schematic diagram of side-chain phenyl isomerization-induced spatial conjugation and backbone interlocking for simultaneous enhancement of photothermal properties and NIR-II emission. ii) Ԑ and iii) photoluminescence (PL) spectra of six fluorophore NPs (Ex = 660 nm laser). Reproduced with permission189. Copyright 2025, Wiley-VCH GmbH. b i) the preparation and in situ self-assembly process of MSDP NPs. ii) The independent gradient model based on the Hirshfeld partition analysis of the dimer of M. Reproduced with permission191. Copyright 2025, Wiley-VCH GmbHCC BY · PubMed Central
Fig. 13 Chemical structures of organic small-molecule metal complex
Fig. 13 Chemical structures of organic small-molecule metal complexCC BY · PubMed Central
Fig. 14 Structures and applications of cyanine-based NIR-II fluorophores in bioimaging. a i) Structure of C7-1080. ii) HRMS of the HSA@C7-1080 complex. iii) Dynamic imaging of sham/stroke mice following tail vein injection of C7-1080 or IR-808Ac. Reproduced with permission107. Copyright 2025, Wiley-VCH GmbH. b i) Structures of Cy15s. ii) NIR-IIb imaging of hindlimb, abdominal, and cerebral vessels in mice. iii) Abdominal NIR-II imaging of orthotopic 4T1 tumor-bearing mice following injection of SJ-1249-Micelles. Reproduced with permission101. Copyright 2025, Elsevier. c i) Structure of NIR-AC4. ii) Brain and iii) tumor vessel imaging of NIR-AC4 NPs in the NIR-II a/b windows. iv) The NIR-IIb intravital imaging of Bio-NPs at different time points post injection. v) The bone NIR-II imaging of Aa-NPs pre/post skin removal. vi) Real-time supine NIR-II fluorescence imaging of normal/osteoporotic mice post injection of Aa-NPs. Reproduced with permission104. Copyright 2025, Wiley-VCH GmbH
Fig. 14 Structures and applications of cyanine-based NIR-II fluorophores in bioimaging. a i) Structure of C7-1080. ii) HRMS of the HSA@C7-1080 complex. iii) Dynamic imaging of sham/stroke mice following tail vein injection of C7-1080 or IR-808Ac. Reproduced with permission107. Copyright 2025, Wiley-VCH GmbH. b i) Structures of Cy15s. ii) NIR-IIb imaging of hindlimb, abdominal, and cerebral vessels in mice. iii) Abdominal NIR-II imaging of orthotopic 4T1 tumor-bearing mice following injection of SJ-1249-Micelles. Reproduced with permission101. Copyright 2025, Elsevier. c i) Structure of NIR-AC4. ii) Brain and iii) tumor vessel imaging of NIR-AC4 NPs in the NIR-II a/b windows. iv) The NIR-IIb intravital imaging of Bio-NPs at different time points post injection. v) The bone NIR-II imaging of Aa-NPs pre/post skin removal. vi) Real-time supine NIR-II fluorescence imaging of normal/osteoporotic mice post injection of Aa-NPs. Reproduced with permission104. Copyright 2025, Wiley-VCH GmbHCC BY · PubMed Central
Fig. 15 Structures and applications of activatable NIR-II cyanine probes in imaging. a i–iii) Structure of cyanine probes (Cy-29, Cy-30, and Cy-31) and corresponding time-dependent NIR-II fluorescence images post intratumor injection. iv) Construction of ATP/ROS dual-responsive theranostic probe Cy-57 and drug release process. v) Time-dependent NIR-II fluorescence imaging across experimental groups. Reproduced with permission206. Copyright 2025, Wiley-VCH GmbH. b i) Structure of DNO. ii) NIR-II imaging of Balb/c mice bearing subcutaneous tumors following intravenous injection of DNO NPs under 808 nm laser excitation. (BC the breast cancer group, DMBC the diabetic BC group) iii) Time-dependent photoacoustic images of DMBC mice following injection of DNO NPs. Reproduced with permission108. Copyright 2025, Wiley-VCH GmbH
Fig. 15 Structures and applications of activatable NIR-II cyanine probes in imaging. a i–iii) Structure of cyanine probes (Cy-29, Cy-30, and Cy-31) and corresponding time-dependent NIR-II fluorescence images post intratumor injection. iv) Construction of ATP/ROS dual-responsive theranostic probe Cy-57 and drug release process. v) Time-dependent NIR-II fluorescence imaging across experimental groups. Reproduced with permission206. Copyright 2025, Wiley-VCH GmbH. b i) Structure of DNO. ii) NIR-II imaging of Balb/c mice bearing subcutaneous tumors following intravenous injection of DNO NPs under 808 nm laser excitation. (BC the breast cancer group, DMBC the diabetic BC group) iii) Time-dependent photoacoustic images of DMBC mice following injection of DNO NPs. Reproduced with permission108. Copyright 2025, Wiley-VCH GmbHCC BY · PubMed Central
Fig. 16 Structures and applications of BODIPY-based NIR-II fluorophores in imaging. a i) The mechanism of NAG detection by BOD-II-NAG-NP in vivo. ii) Fluorescence variation curve of BOD-II-NAG with increasing concentration of NAG. iii) The linear relationship between the fluorescence intensity changes and NAG concentration. iv) NIR-II fluorescence imaging of mice following intravenous injection of BOD-II-NAG-NP. v) NIR-II fluorescence imaging of mice with/without diabetic nephropathy following BOD-II-NAG-NP injection. Reproduced with permission209. Copyright 2021, American Chemical Society. b i) Structure of FBP 912. ii) Time-dependent bioimaging of 4T1-tumour-bearing mice following intravenous injection of FBP 912. iii, iv) In vivo NIR-II imaging (dorsal and ventral views) of renal ischemia-reperfusion mice at different time intervals post-ischemia treatment. Reproduced with permission56. Copyright 2021, Wiley-VCH GmbH. c i) Structure of PTPE3. In vivo NIR-II imaging of ii) whole-body blood vessels, iii) hindlimb vessels, iv) mesenteric micro-circulation and v) tumor vascular system following intravenous injection of PTPE3 NPs. vi) Functional and morphological changes in mesenteric microcirculation visualized by NIR-II fluorescence imaging in the V-PDT process. Reproduced with permission160. Copyright 2023, Elsevier
Fig. 16 Structures and applications of BODIPY-based NIR-II fluorophores in imaging. a i) The mechanism of NAG detection by BOD-II-NAG-NP in vivo. ii) Fluorescence variation curve of BOD-II-NAG with increasing concentration of NAG. iii) The linear relationship between the fluorescence intensity changes and NAG concentration. iv) NIR-II fluorescence imaging of mice following intravenous injection of BOD-II-NAG-NP. v) NIR-II fluorescence imaging of mice with/without diabetic nephropathy following BOD-II-NAG-NP injection. Reproduced with permission209. Copyright 2021, American Chemical Society. b i) Structure of FBP 912. ii) Time-dependent bioimaging of 4T1-tumour-bearing mice following intravenous injection of FBP 912. iii, iv) In vivo NIR-II imaging (dorsal and ventral views) of renal ischemia-reperfusion mice at different time intervals post-ischemia treatment. Reproduced with permission56. Copyright 2021, Wiley-VCH GmbH. c i) Structure of PTPE3. In vivo NIR-II imaging of ii) whole-body blood vessels, iii) hindlimb vessels, iv) mesenteric micro-circulation and v) tumor vascular system following intravenous injection of PTPE3 NPs. vi) Functional and morphological changes in mesenteric microcirculation visualized by NIR-II fluorescence imaging in the V-PDT process. Reproduced with permission160. Copyright 2023, ElsevierCC BY · PubMed Central
Fig. 17 Structures and applications of BBTD-based NIR-II fluorophores in imaging. a i) Structure of NIR-920. ii) NIR-II tumor imaging of 4T1 tumor-bearing mice post intravenous injection of NIR-920 NPs. iii) NIR-II imaging of whole-body lymph node distribution. iv) Images of Left and right leg lymph node using NIR-920 NPs or ICG, respectively, with varying long-pass (LP) filters. v) NIR-II imaging revealed signal accumulation of NIR-920 NPs in the SLN of the 4T1 tumor. vi) Pre- and post-operative lymph node excision imaging. Reproduced with permission126. Copyright 2022, Elsevier. b i) The general procedure for preparation of CTB1125-NPs. ii) NIR-II imaging of specific body regions (right hindlimb, left hindlimb, belly, and brain) in mice post intravenous injection of CTB1125-NPs. iii) Time-dependent NIR-II imaging in mice post CTB1125-NPs injection. iv) NIR-II fluorescence image-guided H22 tumor resection. Reproduced with permission141. Copyright 2024, Wiley-VCH GmbH. c i) Structure of aDTP-TPA. ii) In vivo angiography under different excitation wavelengths. NIR-II imaging of iii) brain vessels and iv) mesenteric blood vessels. v) Tumor accumulation and imaging post intravenous injection of aDTP-TPA NPs. vi) NIR-II fluorescence image-guided 4T1 tumor resection. Reproduced with permission215. Copyright 2025, Wiley-VCH GmbH
Fig. 17 Structures and applications of BBTD-based NIR-II fluorophores in imaging. a i) Structure of NIR-920. ii) NIR-II tumor imaging of 4T1 tumor-bearing mice post intravenous injection of NIR-920 NPs. iii) NIR-II imaging of whole-body lymph node distribution. iv) Images of Left and right leg lymph node using NIR-920 NPs or ICG, respectively, with varying long-pass (LP) filters. v) NIR-II imaging revealed signal accumulation of NIR-920 NPs in the SLN of the 4T1 tumor. vi) Pre- and post-operative lymph node excision imaging. Reproduced with permission126. Copyright 2022, Elsevier. b i) The general procedure for preparation of CTB1125-NPs. ii) NIR-II imaging of specific body regions (right hindlimb, left hindlimb, belly, and brain) in mice post intravenous injection of CTB1125-NPs. iii) Time-dependent NIR-II imaging in mice post CTB1125-NPs injection. iv) NIR-II fluorescence image-guided H22 tumor resection. Reproduced with permission141. Copyright 2024, Wiley-VCH GmbH. c i) Structure of aDTP-TPA. ii) In vivo angiography under different excitation wavelengths. NIR-II imaging of iii) brain vessels and iv) mesenteric blood vessels. v) Tumor accumulation and imaging post intravenous injection of aDTP-TPA NPs. vi) NIR-II fluorescence image-guided 4T1 tumor resection. Reproduced with permission215. Copyright 2025, Wiley-VCH GmbHCC BY · PubMed Central
Fig. 18 Structures and applications of xanthene-based NIR-II fluorophores in imaging. a i) Structure of VIX-4. ii) NIR-II fluorescence imaging of BALB/c mice administered VIX-4 liposomes. NIR-II fluorescence imaging from iii) ventral and iv) dorsal view at representative time points post injection of VIX-4. Reproduced with permission170. Copyright 2021, American Chemical Society. b i) Response mechanism of NIR-Rh-MS to Hg2+/MeHg+. NIR-II fluorescence imaging of mice with ii) acute and iii) chronic mercury poisoning at various time points following intravenous injection of NIR-Rh-MS. iv) NIR-II fluorescence cerebral imaging of mice with MeHgCl-induced mercury poisoning following intravenous injection of NIR-Rh-MS. Reproduced with permission174. Copyright 2022, Elsevier. c i) Structure of VIX-1450. ii) In vivo imaging of the entire vascular system, mesenteric vasculature, intestinal wall blood vessels and cerebral vessels in Balb/c nude mice following injection of VIX-1450 micelles. iii) Dual-channel imaging of ICG (left leg) and VIX-1450 micelles (right leg). Green channel (ICG): abdominal intestine and vasculature; purple-hot channel (VIX-1450): ventral lymphatic system and vasculature. Reproduced with permission175. Copyright 2025, American Chemical Society
Fig. 18 Structures and applications of xanthene-based NIR-II fluorophores in imaging. a i) Structure of VIX-4. ii) NIR-II fluorescence imaging of BALB/c mice administered VIX-4 liposomes. NIR-II fluorescence imaging from iii) ventral and iv) dorsal view at representative time points post injection of VIX-4. Reproduced with permission170. Copyright 2021, American Chemical Society. b i) Response mechanism of NIR-Rh-MS to Hg2+/MeHg+. NIR-II fluorescence imaging of mice with ii) acute and iii) chronic mercury poisoning at various time points following intravenous injection of NIR-Rh-MS. iv) NIR-II fluorescence cerebral imaging of mice with MeHgCl-induced mercury poisoning following intravenous injection of NIR-Rh-MS. Reproduced with permission174. Copyright 2022, Elsevier. c i) Structure of VIX-1450. ii) In vivo imaging of the entire vascular system, mesenteric vasculature, intestinal wall blood vessels and cerebral vessels in Balb/c nude mice following injection of VIX-1450 micelles. iii) Dual-channel imaging of ICG (left leg) and VIX-1450 micelles (right leg). Green channel (ICG): abdominal intestine and vasculature; purple-hot channel (VIX-1450): ventral lymphatic system and vasculature. Reproduced with permission175. Copyright 2025, American Chemical SocietyCC BY · PubMed Central
Fig. 19 Structures and applications of cyano derivatives-based NIR-II fluorophores in imaging. a i) Schematic illustration of LET-7 for visualizing GSH in vivo. ii) Time-dependent NIR-II fluorescence imaging of mice following intratumoral (red circle) and subcutaneous (blue circle) injection of LET-7. Reproduced with permission220. Copyright 2021, American Chemical Society. b i) Structure of MC-PSE and mechanism of GSH detection. ii) Time-dependent NIR-II fluorescence imaging of mice with/without preinjection of NEM (N-ethylmaleimide, a GSH scavenger). Reproduced with permission221. Copyright 2023, American Chemical Society. c i) Schematic illustration for the construction of nanoprobe TX-APN@BSA and the mechanism for responding to APNs. ii) Time-dependent NIR-II fluorescence imaging of tumor-bearing mice following intratumoral injection of TX-APN@BSA. iii) NIR-II fluorescence imaging of model mice on days 10 and 21 post injection of 4T1 cells into the footpad. iv) Photograph and corresponding NIR-II fluorescence image of the model mice post 2nd tumor resection surgery. Reproduced with permission223. Copyright 2022, American Chemical Society
Fig. 19 Structures and applications of cyano derivatives-based NIR-II fluorophores in imaging. a i) Schematic illustration of LET-7 for visualizing GSH in vivo. ii) Time-dependent NIR-II fluorescence imaging of mice following intratumoral (red circle) and subcutaneous (blue circle) injection of LET-7. Reproduced with permission220. Copyright 2021, American Chemical Society. b i) Structure of MC-PSE and mechanism of GSH detection. ii) Time-dependent NIR-II fluorescence imaging of mice with/without preinjection of NEM (N-ethylmaleimide, a GSH scavenger). Reproduced with permission221. Copyright 2023, American Chemical Society. c i) Schematic illustration for the construction of nanoprobe TX-APN@BSA and the mechanism for responding to APNs. ii) Time-dependent NIR-II fluorescence imaging of tumor-bearing mice following intratumoral injection of TX-APN@BSA. iii) NIR-II fluorescence imaging of model mice on days 10 and 21 post injection of 4T1 cells into the footpad. iv) Photograph and corresponding NIR-II fluorescence image of the model mice post 2nd tumor resection surgery. Reproduced with permission223. Copyright 2022, American Chemical SocietyCC BY · PubMed Central
Fig. 20 Structures and applications of cyanine-based NIR-II molecules in phototherapy. a i) Structure of NSCy-1050. ii) Time-dependent NIR-II fluorescence imaging of 4T1 tumor-bearing mice following intravenous injection of NSCy-1050. iii) Photothermal images of mice under different irradiation durations. iv) Representative tumor photographs from different treatment groups at day 20. Reproduced with permission88. Copyright 2023, Wiley-VCH GmbH. b i) Structure of IR1040. ii) Schematic illustration for the preparation of IRNPs-SBA/PtIV. iii) Time-dependent NIR-II fluorescence imaging of Pan02 tumor-bearing mice following intravenous injection of IRNPs-SBA/PtIV. iv) Infrared thermal images of mice at 24 h post intravenous injection of IRNPs-SBA/PtIV under different irradiation durations. v) Photographs of mice pre-treatment (day 0) and post-treatment (day 21). Reproduced with permission95. Copyright 2023, Elsevier. c i) Structure of mCy890. ii) Blood vessel imaging of mice injected with mCy890 NPs. iii) Time-dependent NIR-II fluorescence imaging of tumor-bearing mice following intravenous injection of mCy890 NPs. iv) Photothermal images of mice under different irradiation durations. v) Representative tumor photographs from different treatment groups at day 14. Reproduced with permission93. Copyright 2024, Wiley-VCH GmbH
Fig. 20 Structures and applications of cyanine-based NIR-II molecules in phototherapy. a i) Structure of NSCy-1050. ii) Time-dependent NIR-II fluorescence imaging of 4T1 tumor-bearing mice following intravenous injection of NSCy-1050. iii) Photothermal images of mice under different irradiation durations. iv) Representative tumor photographs from different treatment groups at day 20. Reproduced with permission88. Copyright 2023, Wiley-VCH GmbH. b i) Structure of IR1040. ii) Schematic illustration for the preparation of IRNPs-SBA/PtIV. iii) Time-dependent NIR-II fluorescence imaging of Pan02 tumor-bearing mice following intravenous injection of IRNPs-SBA/PtIV. iv) Infrared thermal images of mice at 24 h post intravenous injection of IRNPs-SBA/PtIV under different irradiation durations. v) Photographs of mice pre-treatment (day 0) and post-treatment (day 21). Reproduced with permission95. Copyright 2023, Elsevier. c i) Structure of mCy890. ii) Blood vessel imaging of mice injected with mCy890 NPs. iii) Time-dependent NIR-II fluorescence imaging of tumor-bearing mice following intravenous injection of mCy890 NPs. iv) Photothermal images of mice under different irradiation durations. v) Representative tumor photographs from different treatment groups at day 14. Reproduced with permission93. Copyright 2024, Wiley-VCH GmbHCC BY · PubMed Central
Fig. 21 Structures and applications of BODIPY-based NIR-II molecules in phototherapy. a i) Structure of aza-BODIPY 5. ii) Time-dependent NIR-II fluorescence imaging of 4T1 tumor-bearing mice post intravenous injection of 5@FAP-NP. iii) IR thermal images of mice post intravenous injection of 5@FAP-NP under different irradiation durations. iv) Representative tumor photographs from different treatment groups of 4T1 tumor-bearing mice following PTT. v) NIR-II fluorescence and vi) photoacoustic imaging of GBM-bearing mice following injection of 5@FAP-NP. Reproduced with permission164. Copyright 2024, SCUT, AIEI, and John Wiley & Sons Australia, Ltd. b i) Structure of TPEB. ii) The general procedure for preparation of TPEB NPs. iii) Time-dependent NIR-II fluorescence imaging of tumor-bearing mice post intravenous injection of TPEB NPs. iv) Thermal images of mice post intravenous injection of TPEB NPs under different irradiation durations. v) Representative tumor photographs from different treatment groups at day 14. Reproduced with permission166. Copyright 2024, Wiley-VCH GmbH. c i) Mechanisms of light-triggered NO release and switching between imaging/phototherapy modes. ii) Time-dependent NIR-II fluorescence imaging of HeLa tumor-bearing mice with/without UV irradiation post subcutaneous injection of BOD-D. iii) Photothermal images of mice under different irradiation durations. Reproduced with permission168. Copyright 2025, SCUT, AIEI, and John Wiley & Sons Australia, Ltd
Fig. 21 Structures and applications of BODIPY-based NIR-II molecules in phototherapy. a i) Structure of aza-BODIPY 5. ii) Time-dependent NIR-II fluorescence imaging of 4T1 tumor-bearing mice post intravenous injection of 5@FAP-NP. iii) IR thermal images of mice post intravenous injection of 5@FAP-NP under different irradiation durations. iv) Representative tumor photographs from different treatment groups of 4T1 tumor-bearing mice following PTT. v) NIR-II fluorescence and vi) photoacoustic imaging of GBM-bearing mice following injection of 5@FAP-NP. Reproduced with permission164. Copyright 2024, SCUT, AIEI, and John Wiley & Sons Australia, Ltd. b i) Structure of TPEB. ii) The general procedure for preparation of TPEB NPs. iii) Time-dependent NIR-II fluorescence imaging of tumor-bearing mice post intravenous injection of TPEB NPs. iv) Thermal images of mice post intravenous injection of TPEB NPs under different irradiation durations. v) Representative tumor photographs from different treatment groups at day 14. Reproduced with permission166. Copyright 2024, Wiley-VCH GmbH. c i) Mechanisms of light-triggered NO release and switching between imaging/phototherapy modes. ii) Time-dependent NIR-II fluorescence imaging of HeLa tumor-bearing mice with/without UV irradiation post subcutaneous injection of BOD-D. iii) Photothermal images of mice under different irradiation durations. Reproduced with permission168. Copyright 2025, SCUT, AIEI, and John Wiley & Sons Australia, LtdCC BY · PubMed Central
Fig. 22 Structures and applications of BBTD-based NIR-II molecules in phototherapy for conventional tumors. a i) Structure of BETA. Time-dependent NIR-II ii) fluorescence and iii) photoacoustic imaging of 4T1 tumor-bearing mice following intravenous injection of BETA NPs. iv) Photothermal images of mice under different irradiation durations. v) Representative tumor photographs from different treatment groups of 4T1 tumor-bearing mice. Reproduced with permission. Reproduced with permission129. Copyright 2022, Wiley-VCH GmbH. b i) The general procedure for preparation of CAT-NP. ii) NIR-II fluorescence, iii) photothermal, and iv) photoacoustic images of CAT-NP in vivo. Reproduced with permission. Reproduced with permission120. Copyright 2022, Wiley-VCH GmbH. c i) Structure of BETT-2. ii) Time-dependent NIR-II fluorescence imaging of 4T1 tumor-bearing mice following intravenous injection of BETT-2 NPs. iii) Thermal images of mice and temperature changes of tumor sites at 12 h post injection of BETT-2 NPs under different irradiation durations. Reproduced with permission. Reproduced with permission139. Copyright 2024, Wiley-VCH GmbH
Fig. 22 Structures and applications of BBTD-based NIR-II molecules in phototherapy for conventional tumors. a i) Structure of BETA. Time-dependent NIR-II ii) fluorescence and iii) photoacoustic imaging of 4T1 tumor-bearing mice following intravenous injection of BETA NPs. iv) Photothermal images of mice under different irradiation durations. v) Representative tumor photographs from different treatment groups of 4T1 tumor-bearing mice. Reproduced with permission. Reproduced with permission129. Copyright 2022, Wiley-VCH GmbH. b i) The general procedure for preparation of CAT-NP. ii) NIR-II fluorescence, iii) photothermal, and iv) photoacoustic images of CAT-NP in vivo. Reproduced with permission. Reproduced with permission120. Copyright 2022, Wiley-VCH GmbH. c i) Structure of BETT-2. ii) Time-dependent NIR-II fluorescence imaging of 4T1 tumor-bearing mice following intravenous injection of BETT-2 NPs. iii) Thermal images of mice and temperature changes of tumor sites at 12 h post injection of BETT-2 NPs under different irradiation durations. Reproduced with permission. Reproduced with permission139. Copyright 2024, Wiley-VCH GmbHCC BY · PubMed Central
Fig. 23 Structures and applications of BBTD-based NIR-II molecules in phototherapy for GBM and PE. a i) The general procedure for preparation of SeP@MT NPs. ii) Time-dependent photoacoustic/ultrasound merged images of GL261 tumor-bearing mice following injection of SeP@MT NPs. iii) Time-dependent bioluminescence images of orthotopic GBM following injection of SeP@MT NPs. Reproduced with permission149. Copyright 2025, Wiley-VCH GmbH. b i) The general procedure for preparation of ApoE@TAhL. ii) Mechanism of synergistic therapy of ApoE@TAhL against in situ GBM. iii) Thermal images of mice post intravenous injection of ApoE@TAhL upon 808 nm laser irradiation. iv) Time-dependent NIR-II fluorescence imaging of GBM-bearing mice following injection of ApoE@TAhL. v) Time-dependent bioluminescence images of orthotopic GBM following injection of ApoE@TAhL. Reproduced with permission234. Copyright 2025, Wiley-VCH GmbH. c i) The general procedure for preparation of 5SGNPs. ii) Time-dependent NIR-II fluorescence signal intensity in the lungs of PE mice following intravenous injection of 5SGNPs. iii) IR thermal images of 5SGNPs-treated PE mice under different irradiation durations. iv) Fluorescence signal intensity of FITC-fibrin in the lungs of mice after different treatments. v) Representative H&E-stained lung sections from different treatment groups. Reproduced with permission236. Copyright 2025, American Chemical Society
Fig. 23 Structures and applications of BBTD-based NIR-II molecules in phototherapy for GBM and PE. a i) The general procedure for preparation of SeP@MT NPs. ii) Time-dependent photoacoustic/ultrasound merged images of GL261 tumor-bearing mice following injection of SeP@MT NPs. iii) Time-dependent bioluminescence images of orthotopic GBM following injection of SeP@MT NPs. Reproduced with permission149. Copyright 2025, Wiley-VCH GmbH. b i) The general procedure for preparation of ApoE@TAhL. ii) Mechanism of synergistic therapy of ApoE@TAhL against in situ GBM. iii) Thermal images of mice post intravenous injection of ApoE@TAhL upon 808 nm laser irradiation. iv) Time-dependent NIR-II fluorescence imaging of GBM-bearing mice following injection of ApoE@TAhL. v) Time-dependent bioluminescence images of orthotopic GBM following injection of ApoE@TAhL. Reproduced with permission234. Copyright 2025, Wiley-VCH GmbH. c i) The general procedure for preparation of 5SGNPs. ii) Time-dependent NIR-II fluorescence signal intensity in the lungs of PE mice following intravenous injection of 5SGNPs. iii) IR thermal images of 5SGNPs-treated PE mice under different irradiation durations. iv) Fluorescence signal intensity of FITC-fibrin in the lungs of mice after different treatments. v) Representative H&E-stained lung sections from different treatment groups. Reproduced with permission236. Copyright 2025, American Chemical SocietyCC BY · PubMed Central
Fig. 24 Structures and applications of xanthene-based NIR-II molecules in phototherapy. a i) The general procedure for preparation of CL4/FBS complex. Time-dependent NIR-II fluorescence imaging of ii) tumor vessels and iii) 4T1 tumor-bearing mice following intravenous injection of CL4/FBS. iv) IR thermal images of CL4/FBS-treated mice under different irradiation durations. Reproduced with permission238. Copyright 2022, Wiley-VCH GmbH. b i) Structure of HTPA. ii) The general procedure for preparation of HTPA NPs and release of HTPA. Time-dependent NIR-II iii) fluorescence and iv) photoacoustic images in subcutaneous 4T1-Luc models following intravenous injection of HTPA NPs. v) Representative tumor photographs from different treatment groups of 4T1 tumor-bearing mice. Reproduced with permission239. Copyright 2025, Wiley-VCH GmbH. c i) The general procedure for preparation of AIEgen bacteria hybrid bionic robot EcN@INX-2. ii) Time-dependent NIR-II fluorescence imaging of tumor-bearing mice following intravenous injection of EcN@INX-2. iii) Photothermal and iv) photoacoustic images of mouse tumor tissue at 24 h post injection of INX-2/EcN@INX-2. v) Representative tumor photographs from different treatment groups of CT26 tumor-bearing mice. Reproduced with permission178. Copyright 2025, Springer Nature
Fig. 24 Structures and applications of xanthene-based NIR-II molecules in phototherapy. a i) The general procedure for preparation of CL4/FBS complex. Time-dependent NIR-II fluorescence imaging of ii) tumor vessels and iii) 4T1 tumor-bearing mice following intravenous injection of CL4/FBS. iv) IR thermal images of CL4/FBS-treated mice under different irradiation durations. Reproduced with permission238. Copyright 2022, Wiley-VCH GmbH. b i) Structure of HTPA. ii) The general procedure for preparation of HTPA NPs and release of HTPA. Time-dependent NIR-II iii) fluorescence and iv) photoacoustic images in subcutaneous 4T1-Luc models following intravenous injection of HTPA NPs. v) Representative tumor photographs from different treatment groups of 4T1 tumor-bearing mice. Reproduced with permission239. Copyright 2025, Wiley-VCH GmbH. c i) The general procedure for preparation of AIEgen bacteria hybrid bionic robot EcN@INX-2. ii) Time-dependent NIR-II fluorescence imaging of tumor-bearing mice following intravenous injection of EcN@INX-2. iii) Photothermal and iv) photoacoustic images of mouse tumor tissue at 24 h post injection of INX-2/EcN@INX-2. v) Representative tumor photographs from different treatment groups of CT26 tumor-bearing mice. Reproduced with permission178. Copyright 2025, Springer NatureCC BY · PubMed Central
Fig. 25 Structures and applications of cyano derivatives-based NIR-II molecules in phototherapy. a i) Structure of FE-IDMN. ii) Time-dependent NIR-II fluorescence imaging of 4T1 tumor-bearing mice following intratumoral injection of FE-IDMN NPs. iii) Photothermal images of mouse tumor tissue at 4 h post injection of FE-IDMN NPs under different irradiation durations. iv) Representative tumor photographs from different treatment groups at day 14. Reproduced with permission187. Copyright 2023, Wiley-VCH GmbH. b i) Structure of TTP. ii) Time-dependent NIR-II fluorescence imaging of MCF-7 tumor-bearing mice following injection of TTP NPs. iii) Infrared thermal images of mouse tumor tissue post injection of TTP NPs under different irradiation durations. iv) Representative tumor photographs from different treatment groups of MCF-7 tumor-bearing mice. Reproduced with permission188. Copyright 2024, Wiley-VCH GmbH. c i) Schematic illustration of the preparation and in situ self-assembly process of MSDP NPs. ii) Time-dependent NIR-II fluorescence imaging of H22 tumor-bearing mice following intravenous injection of MSDP NPs. iii) Representative tumor photographs from different treatment groups of H22 tumor-bearing mice. Reproduced with permission191. Copyright 2025, Wiley-VCH GmbH
Fig. 25 Structures and applications of cyano derivatives-based NIR-II molecules in phototherapy. a i) Structure of FE-IDMN. ii) Time-dependent NIR-II fluorescence imaging of 4T1 tumor-bearing mice following intratumoral injection of FE-IDMN NPs. iii) Photothermal images of mouse tumor tissue at 4 h post injection of FE-IDMN NPs under different irradiation durations. iv) Representative tumor photographs from different treatment groups at day 14. Reproduced with permission187. Copyright 2023, Wiley-VCH GmbH. b i) Structure of TTP. ii) Time-dependent NIR-II fluorescence imaging of MCF-7 tumor-bearing mice following injection of TTP NPs. iii) Infrared thermal images of mouse tumor tissue post injection of TTP NPs under different irradiation durations. iv) Representative tumor photographs from different treatment groups of MCF-7 tumor-bearing mice. Reproduced with permission188. Copyright 2024, Wiley-VCH GmbH. c i) Schematic illustration of the preparation and in situ self-assembly process of MSDP NPs. ii) Time-dependent NIR-II fluorescence imaging of H22 tumor-bearing mice following intravenous injection of MSDP NPs. iii) Representative tumor photographs from different treatment groups of H22 tumor-bearing mice. Reproduced with permission191. Copyright 2025, Wiley-VCH GmbHCC BY · PubMed Central
Fig. 26 Structures and applications of metal complexes-based NIR-II molecules in phototherapy. a i) Structure of Ru-1. ii) NIR-II fluorescent imaging of Staphylococcus aureus and Escherichia coli at 2 h post incubation with Ru-1. iii) Time-dependent NIR-II fluorescence imaging of Staphylococcus aureus–infected wound models following intravenous injection of Ru-1 NPs. Reproduced with permission197. Copyright 2022, Natl. Acad. Sciences. b i) Structure of Ru1000. ii) Time-dependent NIR-II fluorescence imaging of A549 tumor-bearing mice following intratumoral injection of Ru1000. iii) IR thermal images of Ru1000-treated mice under different irradiation durations. Reproduced with permission195. Copyright 2022, Wiley-VCH GmbH. c i) Structure of DPTPzIr. ii) Time-dependent NIR-II fluorescence imaging of 4T1 tumor-bearing mice following intravenous injection of DPTPzIr NPs. iii) Photothermal images of DPTPzIr NPs-treated mice under different irradiation durations. iv) Tumor growth profiles from different treatment groups at day 15. Reproduced with permission245. Copyright 2025, American Chemical Society
Fig. 26 Structures and applications of metal complexes-based NIR-II molecules in phototherapy. a i) Structure of Ru-1. ii) NIR-II fluorescent imaging of Staphylococcus aureus and Escherichia coli at 2 h post incubation with Ru-1. iii) Time-dependent NIR-II fluorescence imaging of Staphylococcus aureus–infected wound models following intravenous injection of Ru-1 NPs. Reproduced with permission197. Copyright 2022, Natl. Acad. Sciences. b i) Structure of Ru1000. ii) Time-dependent NIR-II fluorescence imaging of A549 tumor-bearing mice following intratumoral injection of Ru1000. iii) IR thermal images of Ru1000-treated mice under different irradiation durations. Reproduced with permission195. Copyright 2022, Wiley-VCH GmbH. c i) Structure of DPTPzIr. ii) Time-dependent NIR-II fluorescence imaging of 4T1 tumor-bearing mice following intravenous injection of DPTPzIr NPs. iii) Photothermal images of DPTPzIr NPs-treated mice under different irradiation durations. iv) Tumor growth profiles from different treatment groups at day 15. Reproduced with permission245. Copyright 2025, American Chemical SocietyCC BY · PubMed Central

Verification

Claims the paper makes

68 Valid · 2 Not valid · 232 Not checked · 41 Own results and interpretations

155 more claims · 27 with their cited sources checked

Create a free account to see all 343 claims and to verify the 11 references still open.

See all claims — free account
  • It may state two separate claims as one. 160
  • Probably not a substantial claim. 27

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 245 references

Cited by

See all 22

Metadata

Authors
Xiang, D., Wang, Z., Zheng, H., Tang, Y., & Li, Q.
Affiliations
  • Southeast University (CN)
  • Kent State University (US)
Corresponding author
  • Tang, Yuqi
  • Li, Quan
Venue
Light: Science & Applications
Published
2026-03-16
Volume
15
Issue
1
ISSN
2047-7538 (ISSN-L)
OpenAlex
W7136297032
Cited by
22
References
123
Citations by year
2026: 22
FWCI
7.18
Type
journal article
Language
en
Open access
Licence
Locations
  • Light Science & Applications (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Physical Sciences › Materials Science › Materials Chemistry › Luminescence and Fluorescent Materials
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Physical Sciences › Chemistry › Spectroscopy › Molecular Sensors and Ion Detection
Keywords
NIR-II fluorophores, deep tissue imaging, photodynamic therapy, photothermal therapy, cyanine dyes, boron dipyrromethene, benzobisthiadiazole, xanthene derivatives, structure-function relationship, photophysical properties, molecular engineering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Organic small-molecule NIR-II fluorophores for tumor phototheranostics. https://app.cochat.ai/papers/10.1038/s41377-026-02212-w
The paper
Xiang, D., Wang, Z., Zheng, H., Tang, Y., & Li, Q. (2026). Organic small-molecule NIR-II fluorophores for tumor phototheranostics. Light: Science & Applications. https://doi.org/10.1038/s41377-026-02212-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.